Projects per year
Fingerprint
Network
Profiles
-
-
Nasal RNA response to respiratory viral infections
Pan, T. T. & Simon, V.
National Institute of Allergy and Infectious Diseases
1/04/22 → 31/03/23
Project: Research
-
A deep longitudinal analysis of next generation influenza vaccines in older adults
Garcia-Sastre, A., Garcia-sastre, A. A. & Kuchel, G. G. A.
National Institute of Allergy and Infectious Diseases
1/01/22 → 31/12/23
Project: Research
-
Multi-dimensional comparison of differentially pathogenic coronaviruses (CoV) in human lung tissue
Lim, J. J. K., Johnson, J. R., Johnson, J. & Lim, J. K.
National Institute of Allergy and Infectious Diseases
24/09/21 → 31/08/23
Project: Research
-
Experimental and natural SARS-CoV-2 infection of the human pancreas
Homann, D., Homann, D., Schotsaert, M. M. & Schotsaert, M.
National Institute of Diabetes and Digestive and Kidney Diseases
17/09/21 → 31/08/23
Project: Research
-
Decode the Impact of SARS-CoV-2 on Human Pancreas
Chen, S. S., Chen, S., tenOever, B., Schwartz, R. R. E., Schwartz, R. E. & Tenoever, B. R.
National Institute of Diabetes and Digestive and Kidney Diseases
5/07/21 → 30/06/23
Project: Research
-
Molecular Mechanisms of the Dysregulated Immune Response to Ebola Virus
Bukreyev, A. A., Bukreyev, A., Garcia-Blanco, M. A., Marazzi, I., Garcia-blanco, M. M. A., Rajsbaum, R. & Routh, A. L.
15/04/21 → 31/03/23
Project: Research
-
Vulnerability of SARS- CoV-2 Infection in Lung Cancer Based on Serological Antibody Analyses
Hirsch, F., Garcia-Sastre, A., Krammer, F., Garcia-Sastre, A., Hirsch, F. R., Krammer, F., Mack, P. C., Mack, P. P. C., Shyr, Y. & Shyr, Y. Y.
30/09/20 → 31/08/23
Project: Research
-
Dynamic regulatory network models of human response to influenza virus
Marazzi, I., Miraldi, E. E., Marazzi, I. & Miraldi, E.
National Institute of Allergy and Infectious Diseases
17/08/20 → 31/05/23
Project: Research
Research output
-
Evaluation and validation of an RT-PCR assay for specific detection of monkeypox virus (MPXV)
Paniz-Mondolfi, A., Guerra, S., Muñoz, M., Luna, N., Hernandez, M. M., Patino, L. H., Reidy, J., Banu, R., Shrestha, P., Liggayu, B., Umeaku, A., Chen, F., Cao, L., Patel, A., Hanna, A., Li, S., Look, A., Pagani, N., Albrecht, R., Pearl, R., & 24 others , Jan 2023, In: Journal of Medical Virology. 95, 1, e28247.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
2022 taxonomic update of phylum Negarnaviricota (Riboviria: Orthornavirae), including the large orders Bunyavirales and Mononegavirales
Kuhn, J. H., Adkins, S., Alkhovsky, S. V., Avšič-Županc, T., Ayllón, M. A., Bahl, J., Balkema-Buschmann, A., Ballinger, M. J., Bandte, M., Beer, M., Bejerman, N., Bergeron, É., Biedenkopf, N., Bigarré, L., Blair, C. D., Blasdell, K. R., Bradfute, S. B., Briese, T., Brown, P. A., Bruggmann, R., & 161 others , Dec 2022, In: Archives of Virology. 167, 12, p. 2857-2906 50 p.Research output: Contribution to journal › Article › peer-review
Open Access -
ACE2-IgG1 fusions with improved in vitro and in vivo activity against SARS-CoV-2
Iwanaga, N., Cooper, L., Rong, L., Maness, N. J., Beddingfield, B., Qin, Z., Crabtree, J., Tripp, R. A., Yang, H., Blair, R., Jangra, S., García-Sastre, A., Schotsaert, M., Chandra, S., Robinson, J. E., Srivastava, A., Rabito, F., Qin, X. & Kolls, J. K., 21 Jan 2022, In: iScience. 25, 1, 103670.Research output: Contribution to journal › Article › peer-review
Open Access5 Scopus citations -
Activity of convalescent and vaccine serum against SARS-CoV-2 Omicron
PSP-PARIS Study Group, 24 Feb 2022, In: Nature. 602, 7898, p. 682-688 7 p.Research output: Contribution to journal › Article › peer-review
Open Access185 Scopus citations -
Advances and gaps in SARS-CoV-2 infection models
Muñoz-Fontela, C., Widerspick, L., Albrecht, R. A., Beer, M., Carroll, M. W., de Wit, E., Diamond, M. S., Dowling, W. E., Funnell, S. G. P., García-Sastre, A., Gerhards, N. M., de Jong, R., Munster, V. J., Neyts, J., Perlman, S., Reed, D. S., Richt, J. A., Riveros-Balta, X., Roy, C. J., Salguero, F. J., & 7 others , Jan 2022, In: PLoS Pathogens. 18, 1, e1010161.Research output: Contribution to journal › Review article › peer-review
Open Access17 Scopus citations -
A multinational Delphi consensus to end the COVID-19 public health threat
The COVID-19 Consensus Statement Panel, 10 Nov 2022, In: Nature. 611, 7935, p. 332-345 14 p.Research output: Contribution to journal › Article › peer-review
Open Access7 Scopus citations -
An intranasal recombinant NDV-BRSV Fopt vaccine is safe and reduces lesion severity in a colostrum-deprived calf model of RSV infection
Sacco, R. E., Mena, I., Palmer, M. V., Durbin, R. K., García-Sastre, A. & Durbin, J. E., Dec 2022, In: Scientific Reports. 12, 1, 22552.Research output: Contribution to journal › Article › peer-review
Open Access -
Antibodies targeting the neuraminidase active site inhibit influenza H3N2 viruses with an S245N glycosylation site
Stadlbauer, D., McMahon, M., Turner, H. L., Zhu, X., Wan, H., Carreño, J. M., O’Dell, G., Strohmeier, S., Khalil, Z., Luksza, M., van Bakel, H., Simon, V., Ellebedy, A. H., Wilson, I. A., Ward, A. B. & Krammer, F., Dec 2022, In: Nature Communications. 13, 1, 7864.Research output: Contribution to journal › Article › peer-review
Open Access -
A Robust, Highly Multiplexed Mass Spectrometry Assay to Identify SARS-CoV-2 Variants
Mount Sinai PSP Study Group, Sep 2022, In: Microbiology spectrum. 10, 5Research output: Contribution to journal › Article › peer-review
Open Access -
A translational genomics approach identifies IL10RB as the top candidate gene target for COVID-19 susceptibility
VA Million Veteran Program COVID-19 Science Initiative & Mount Sinai COVID-19 Biobank, Dec 2022, In: npj Genomic Medicine. 7, 1, 52.Research output: Contribution to journal › Article › peer-review
Open Access -
Augmentation of humoral and cellular immune responses after third-dose SARS-CoV-2 vaccination and viral neutralization in myeloma patients
PVI/MM/Seronet Study Group, 9 May 2022, In: Cancer Cell. 40, 5, p. 441-443 3 p.Research output: Contribution to journal › Letter › peer-review
Open Access11 Scopus citations -
Author Correction: Clonally expanded CD8 T cells characterize amyotrophic lateral sclerosis-4 (Nature, (2022), 606, 7916, (945-952), 10.1038/s41586-022-04844-5)
Campisi, L., Chizari, S., Ho, J. S. Y., Gromova, A., Arnold, F. J., Mosca, L., Mei, X., Fstkchyan, Y., Torre, D., Beharry, C., Garcia-Forn, M., Jiménez-Alcázar, M., Korobeynikov, V. A., Prazich, J., Fayad, Z. A., Seldin, M. M., De Rubeis, S., Bennett, C. L., Ostrow, L. W., Lunetta, C., & 6 others , 25 Aug 2022, In: Nature. 608, 7924, p. E34Research output: Contribution to journal › Comment/debate
Open Access
Press / Media
-
Are some people immune to COVID-19?
Noam Beckmann & Benjamin tenOever,
19/01/23
1 item of Media coverage
Press/Media
-
A Statement From Scientists On The Use And Threats Of Use Of Nuclear Weapons
David Wolfe, Robert Fisher, David Cohen & Jeffrey Johnson
17/01/23
1 item of Media coverage
Press/Media
-
The covid variant that most threatens Europe does not come from China but from the USA.
3/01/23
1 item of Media coverage
Press/Media
-
Icahn School Of Medicine At Mount Sinai Continues Drive To Diversify Research
5/12/22
1 item of Media coverage
Press/Media
-
-
Icahn School of Medicine at Mount Sinai Continues Drive to Diversify Research by Appointing New Biomedical Laureates
30/11/22 → 1/12/22
2 items of Media coverage
Press/Media
-
-
A Universal Flu Vaccine Using RNA Technology Successfully Tested in Mice | Science
1/12/22
1 item of Media coverage
Press/Media
-
Landmark 20-strain mRNA flu vaccine looks to prevent future pandemics
27/11/22 → 28/11/22
2 items of Media coverage
Press/Media
-
Researchers discover a new type of RNA that inhibits a broad range of viral infections
Benjamin tenOever,
25/11/22
1 item of Media coverage
Press/Media
-
Universal flu vaccine using RNA technology successfully tested in mice
24/11/22 → 25/11/22
2 items of Media coverage
Press/Media
-